Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves
Author(s) -
Andreas Schaefer,
Hendrik Treede,
Gerhard Schoen,
Florian Deuschl,
Niklas Schofer,
Y. Schneeberger,
Stefan Blankenberg,
Hermann Reichenspurner,
Ulrich Schäefer,
Lenard Conradi
Publication year - 2016
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezw021
Subject(s) - cardiology , medicine , first generation , environmental health , population
The published literature has extensively documented clinical benefit derived from transcatheter aortic valve implantation (TAVI) in high-risk patients using self-expanding current-generation transfemoral (TF) transcatheter heart valves (THVs). However, it has also demonstrated apparent shortcomings such as paravalvular leakage (PVL) or need for permanent pacemaker (PM) implantation. We here present a case-matched analysis of acute 30-day outcomes using a novel nitinol-based THV (Symetis Acurate Neo TF™), which may overcome some limitations of currently used devices.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom